Anders Jacobson
Direktor/Vorstandsmitglied bei KLARIA PHARMA HOLDING AB
Vermögen: 7 008 $ am 31.05.2024
Aktive Positionen von Anders Jacobson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SENZIME AB | Corporate Officer/Principal | 01.02.2022 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | 01.02.2022 | |
KLARIA PHARMA HOLDING AB | Direktor/Vorstandsmitglied | 01.01.2022 | - |
Independent Dir/Board Member | 01.01.2022 | - | |
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Anders Jacobson
Ehemalige bekannte Positionen von Anders Jacobson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACARIX AB | Direktor/Vorstandsmitglied | 01.01.2020 | 11.05.2021 |
Ausbildung von Anders Jacobson
University of Uppsala | Graduate Degree |
Statistik
International
Schweden | 6 |
Operativ
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SENZIME AB | Health Technology |
ACARIX AB | Health Technology |
KLARIA PHARMA HOLDING AB | Health Technology |
Private Unternehmen | 1 |
---|---|
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Health Services |
- Börse
- Insiders
- Anders Jacobson
- Erfahrung